Articles of Vaccines

News »

Itolizumab monoclonal antibody in the COVID-19 battle

interferon cuba

In 2014 the novel medication won a National Award from the Cuban Academy of Sciences (ACC) in the Biomedical Sciences arena, and since April, this year, the humanized monoclonal antibody, Itolizumab, has been included in the country’s COVID-19 treatment protocol. To learn first-hand about the characteristics and indications of this drug, created at the Center for Molecular Immunology (CIM), and winner of the World Intellectual Property Organization (WIPO) Gold Medal in 2015.

News »

Cuba, Vietnam Favor More Cooperation between Vaccine Producers

vacuna2

The Finlay Vaccine Institute (IFV) in Cuba and its Vietnamese counterpart, Vabiotech, signed a memorandum of understanding in this capital to boost cooperation relations. The document establishes the access to new technologies and products in an advanced stage as a key aspect, as well as new markets and possibilities of development, IFV Deputy Director Yury Valdes told Prensa Latina.